Trademark: 87812220
Word
CAPRE
Status
Registered
Status Code
700
Status Date
Tuesday, April 9, 2019
Serial Number
87812220
Registration Number
5719474
Registration Date
Tuesday, April 9, 2019
Mark Type
4000
Filing Date
Tuesday, February 27, 2018
Published for Opposition
Tuesday, January 22, 2019
Trademark Owner History
Acasti Pharma Inc. - Original Registrant
Classifications
5 Pharmaceutical preparations for lowering LDL-cholesterol and triglycerides, for increasing HDL and regulating glucose intolerance
Trademark Events
Apr 9, 2024
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Apr 9, 2019
Registered-Principal Register
Jan 22, 2019
Official Gazette Publication Confirmation E-Mailed
Jan 22, 2019
Published For Opposition
Jan 2, 2019
Notification Of Notice Of Publication E-Mailed
Dec 13, 2018
Approved For Pub - Principal Register
Dec 13, 2018
Teas/Email Correspondence Entered
Dec 13, 2018
Correspondence Received In Law Office
Dec 6, 2018
Assigned To Lie
Dec 2, 2018
Teas Response To Suspension Inquiry Received
Jun 15, 2018
Notification Of Letter Of Suspension E-Mailed
Jun 15, 2018
Letter Of Suspension E-Mailed
Jun 15, 2018
Suspension Letter Written
Jun 12, 2018
Assigned To Examiner
Mar 5, 2018
New Application Office Supplied Data Entered
Mar 2, 2018
New Application Entered
87812219
EVERYWHERE
Trademark Alertz updated from USPTO on 2030-01-24

Trademark Alertz ™ - Twit Solutions PTY LTD 2024 - Privacy Policy - Terms of Use

The information provided on Trademark Alertz is not legal or professional advice. Information may have been obtained from third parties and may contain errors. You must make your own enquiries and seek independent advice from relevant industry professionals before acting or relying on any information from Trademark Alertz. All trade mark information has been obtained from and made publicly available by The United States Patent and Trademark Office (USPTO). Copyright of the trademark data resides with USPTO. www.uspto.gov